Vascular Endothelial Growth Factor Expression Patterns in non- Human Papillomavirus – Related Pterygia: An Experimental Study on Cell Spot Arrays Digital Analysis

References

• Bradley JC, Yang W, Bradley RH, Reid TW, Schwab IR. The science of pterygia. Br J Ophthalmol. 2010;94(7):815–820. doi:10.1136/bjo.2008.151852.
   PubMed Web of Science ®Google Scholar
• Detorakis ET, Spandidos DA. Pathogenetic mechanisms and treatment options for ophthalmic pterygium: trends and perspectives. Int J Mol Med. 2009;23(4):439–447.
   PubMed Web of Science ®Google Scholar
• Liu T, Liu Y, Xie L, He X, Bai J. Progress in the pathogenesis of pterygium. Curr Eye Res. 2013;38(12):1191–1197. doi:10.3109/02713683.2013.823212.
   PubMed Web of Science ®Google Scholar
• Janson BJ, Sikder S. Surgical management of pterygium. Ocul Surf. 2014;12(2):112–119. doi:10.1016/j.jtos.2014.01.001.
   PubMed Web of Science ®Google Scholar
• Singh H, Laad S, Pattebahadur RS, Saluja P, Ramnani P. A comparative study of postoperative outcome after pterygium excision using autologous blood and sutures. J Evid Based Med. 2017;4(95):6022–6027.
   Google Scholar
• Rezvan F, Khabazkhoob M, Hooshmand E, Yekta A, Saatchi M, Hashemi H. Prevalence and risk factors of pterygium: a systematic review and meta-analysis. Surv Ophthalmol. 2018;63(5):719–735. doi:10.1016/j.survophthal.2018.03.001.
   PubMed Web of Science ®Google Scholar
• Cárdenas-Cantú E, Zavala J, Valenzuela J, Valdez-García JE. Molecular basis of pterygium development. Semin Ophthalmol. 2016;31(6):567–583.
   PubMed Web of Science ®Google Scholar
• Kim KW, Ha HS, Kim JC. Ischemic tissue injury and progenitor cell tropism: significant contributors to the pathogenesis of pterygium. Histol Histopathol. 2015;30:311–320.
   PubMed Web of Science ®Google Scholar
• Karukonda SR, Thompson HW, Beuerman RW, Lam DS, Wilson R, Chew SJ, Steinemann TL. Cell cycle kinetics in pterygium at three latitudes. Br J Ophthalmol. 1995;79(4):313–317. doi:10.1136/bjo.79.4.313.
   PubMed Web of Science ®Google Scholar
• Tan DT, Tang WY, Liu YP, Goh HS, Smith DR. Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium. Br J Ophthalmol. 2000;84(2):212–216. doi:10.1136/bjo.84.2.212.
   PubMed Web of Science ®Google Scholar
• Folkman J, Klagsbrun M. Angiogenic factors. Science. 1987;235(4787):442–447. doi:10.1126/science.2432664.
   PubMed Web of Science ®Google Scholar
• Veikkola T, Alitalo K. VEGFs, receptors and angiogenesis. Semin Cancer Biol. 1999;9(3):211–220. doi:10.1006/scbi.1998.0091.
   PubMed Web of Science ®Google Scholar
• Dvorak HF. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol. 2002;20(21):4368–4380. doi:10.1200/JCO.2002.10.088.
   PubMed Web of Science ®Google Scholar
• Strieter RM. Masters of angiogenesis. Nat Med. 2005;11(9):925–927. doi:10.1038/nm0905-925.
   PubMed Web of Science ®Google Scholar
• Semenza GL, Agani F, Feldser D, Iyer N, Kotch L, Laughner E, Yu A. Hypoxia, HIF-1, and the pathophysiology of common human diseases. Adv Exp Med Biol. 2000;475:123–130. doi:10.1007/0-306-46825-5_12.
   PubMed Web of Science ®Google Scholar
• Ferrara N, Hillan KJ, Gerber HP, Novotny W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov. 2004;3(5):391–400. doi:10.1038/nrd1381.
   PubMed Web of Science ®Google Scholar
• Thorpe PE. Vascular targeting agents as cancer therapeutics. Clin Cancer Res. 2004;10(2):415–427. doi:10.1158/1078-0432.ccr-0642-03.
   PubMed Web of Science ®Google Scholar
• Meng Q, Qin Y, Deshpande M, Kashiwabuchi F, Rodrigues M, Lu Q, Ren H, Elisseeff JH, Semenza GL, Montaner SV, et al. Hypoxia-inducible factor-dependent expression of angiopoietin-like 4 by conjunctival epithelial cells promotes the angiogenic phenotype of pterygia. Invest Ophthalmol Vis Sci. 2017;58(11):4514–4523.
   PubMed Web of Science ®Google Scholar
• Pagoulatos D, Pharmakakis N, Lakoumentas J, Assimakopoulou M. Etaypoxia-inducible factor-1alpha, von Hippel-Lindau protein, and heat shock protein expression in ophthalmic pterygium and normal conjunctiva. Mol Vis. 2014;20:441–457.
   PubMed Web of Science ®Google Scholar
• Xin X, Rodrigues M, Umapathi M, Kashiwabuchi F, Ma T, Babapoor-Farrokhran S, Wang S, Hu J, Bhutto I, Welsbie DS, et al. Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent upregulation of angiopoietin-like 4. Proc Natl Acad Sci USA. 2013;110(36):E3425–E3434.
   PubMed Web of Science ®Google Scholar
• Lee DH, Cho HJ, Kim JT, Choi JS, Joo CK. Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia. Cornea. 2001;20:738–742.
   PubMed Web of Science ®Google Scholar
• Kim KW, Lee SJ, Kim JC. TNF-α upregulates HIF-1α expression in pterygium fibroblasts and enhances their susceptibility to VEGF independent of hypoxia. Exp Eye Res. 2017;164:74–81. doi:10.1016/j.exer.2017.08.008.
   PubMed Web of Science ®Google Scholar
• Liu D, Peng C, Jiang Z, Tao L. Relationship between expression of cyclooxygenase 2 and neovascularization in human pterygia. Oncotarget. 2017;8(62):105630–105636. doi:10.18632/oncotarget.22351.
   PubMedGoogle Scholar
• Mauro J, Foster CS. Pterygia: pathogenesis and the role of subconjunctival bevacizumab in treatment. Semin Ophthalmol. 2009;24(3):130–134. doi:10.1080/08820530902801106.
   PubMed Web of Science ®Google Scholar
• Enkvetchakul O, Thanathanee O, Rangsin R, Lekhanont K, Suwan-Apichon O. A randomized controlled trial of intralesional bevacizumab injection on primary pterygium: preliminary results. Cornea. 2011;30(11):1213–1218. doi:10.1097/ICO.0b013e31821c9b44.
   PubMed Web of Science ®Google Scholar
• Mak RK, Chan TCY, Marcet MM, Choy BNK, Shum JWH, Shih KC, Wong IYH, Ng ALK. Use of anti-vascular endothelial growth factor in the management of pterygium. Acta Ophthalmol. 2017;95(1):20–27. doi:10.1111/aos.13178.
   PubMed Web of Science ®Google Scholar
• Wu M, Wang J, Zhang Q, Wang Y, Niu L, Shao T. Overexpression of low-density lipoprotein receptors stimulated by vascular endothelial growth factor in fibroblasts from pterygium. Biomed Pharmacother. 2017;93:609–615. doi:10.1016/j.biopha.2017.06.090.
   PubMed Web of Science ®Google Scholar
• Tsiambas E, Karameris A, Lygeros M, Athanasiou AE, Salemis NS, Gourgiotis S, Ragkos V, Metaxas GE, Vilaras G, Patsouris E. Gene numerical imbalances in cytological specimens based on fluorescence/chromogenic in situ hybridization analysis. 2012;17(3):593–599.
   Google Scholar
• Kayat KV, Correa Dantas PE, Felberg S, Galvao MA, Saieg MA. Exfoliative cytology in the diagnosis of ocular surface squamous neoplasms. Cornea. 2017;36(1):127–130. doi:10.1097/ICO.0000000000001027.
   PubMed Web of Science ®Google Scholar
• Konstantopoulou K, Tsiambas E, Baliou E, Lazaris AC, Kavantzas N, Karameris A, Fotiades PP, Asproudis I, Ragos V, Vilaras G, et al. Deregulation of p53 and survivin apoptotic markers in pterygium correlated to PTEN expression. JBUON. 2018;23(3):826–831.
   Google Scholar
• Chrysovergis A, Papanikolaou VS, Tsiambas E, Ragos V, Peschos D, Kyrodimos E. Digital analysis of BCL2 expression in laryngeal squamous cell carcinoma. Anticancer Res. 2019;39(3):1253–1257. doi:10.21873/anticanres.13235.
   PubMed Web of Science ®Google Scholar
• Tsiambas E, Riziotis C, Mastronikolis NS, Peschos D, Mortakis A, Kyroysis G, Mastronikolis SN, Batistatou A, Lazaris AC, Patsouris E, et al. Comparative p16IKN4A expression in laryngeal carcinoma and cervical cancer precursors: a real-time grid-based immunocytochemistry analysis. Anticancer Res. 2018;38(10):5805–5810. doi:10.21873/anticanres.12920.
   PubMed Web of Science ®Google Scholar
• Aspiotis M, Tsanou E, Gorezis S, Ioachim E, Skyrlas A, Stefaniotou M, Malamou-Mitsi Vl. Angiogenesis in pterygium: study of microvessel density, vascular endothelial  growth factor, and thrombospondin-1. Eye. 2007;21:1095–1101. doi:10.1038/sj.eye.6702495.
   PubMed Web of Science ®Google Scholar
• Marcovich AL, Morad Y, Sandbank J, Huszar M, Rosner M, Pollack A, Herbert M, Bar-Dayan Y. Angiogenesis in  pterygium: morphometric and immunohistochemical study. Curr Eye Res. 2002;25:17–22. doi:10.1076/ceyr.25.1.17.9959.
   PubMed Web of Science ®Google Scholar
• Elgouhary SM, Elmazar HF, Naguib MI, Bayomy NR. Role of oxidative stress and vascular endothelial growth factor expression in pterygium pathogenesis and prevention of pterygium recurrence after surgical excision. Int Ophthalmol. 2020;40(10):2593–2606. doi:10.1007/s10792-020-01440-2.
   PubMed Web of Science ®Google Scholar
• Martín-López J, Pérez-Rico C, García-Honduvilla N, Buján J, Pascual G. Elevated blood/lymphatic vessel ratio in pterygium and its relationship with Vascular Endothelial Growth Factor (VEGF) distribution. Histol Histopathol. 2019;34(8):917–929.
   PubMed Web of Science ®Google Scholar
• Uthaithammarat L, Kasetsuwan N, Chongpison Y, Kasetsuwan P, Reinprayoon U, Nilyanimit P, Poovorawan Y. Lack of HPV in pterygium with no evidence of autoinoculation and the role of cytokines in pterygium with dry eye. Sci Rep. 2021;11(1):2842. doi:10.1038/s41598-021-82114-6.
   PubMed Web of Science ®Google Scholar
• Chalkia AK, Bontzos G, Spandidos DA, Detorakis ET. Human papillomavirus infection and ocular surface disease. Int J Oncol. 2019;54(5):1503–1510.
   PubMed Web of Science ®Google Scholar
• Otlu B, Emre S, Turkcuoglu P, Doganay S, Durmaz R. Investigation of human papillomavirus and Epstein–Barr virus DNAs in pterygium tissue. Eur J Ophthalmol. 2009;19:175–179.
   PubMed Web of Science ®Google Scholar
• Chong PP, Tung CH, Rahman NABA, Yajima M, Chin FW, Yeng CLS, Go ES, Chan CML, Yawata N, Yamamoto N. Prevalence and viral load of oncogenic human papillomavirus (HPV) in pterygia in multi-ethnic patients in the Malay Peninsula. Acta Ophthalmol. 2014;92(7):e569–e579. doi:10.1111/aos.12427.
   PubMed Web of Science ®Google Scholar